To mark this year’s World Malaria Day, the WWARN and IDDO team will attend events in the UK to encourage continued discussion on antimalarial resistance in efforts to eliminate the disease.

The Clinical Data Interchange Standards Consortium (CDISC) and the WorldWide Antimalarial Resistance Network (WWARN) are pleased to announce the availability of CDISC Malaria Therapeutic Area (TA) User Guide v1.0, the very first global malaria data standard that enables data capture and assessment f...

The Asia Malaria Images project and exhibition aims to portray those affected most by malaria living in rural settings through photography.

The third Quality of Medical Products and Public Health course will take place in Boston, USA this year, from 10-14 July. The course is a pioneering initiative developed by the London School of Hygiene & Tropical Medicine and the University of Oxford.

The National Institutes of Health (NIH) have just announced a new funding opportunity for infectious disease researchers.

A booklet aimed at the general public examines the supply chain and how market globalisation put the quality of medicines at stake.

In a new study out this week in the Lancet Infectious Diseases, researchers have found that a dominant strain of drug resistant falciparum malaria, first detected in 2008 in Cambodia, has spread to other countries in the Greater Mekong Sub-region of Southeast Asia.

A lineage of multidrug resistant P. falciparum malaria superbugs has widely spread and is now established in parts of Thailand, Laos and Cambodia, causing high treatment failure rates for the main falciparum malaria medicines, artemisinin combination therapies (ACTs), according to a study published ...

Bill Gates and Ray Chambers have convened the ‘End Malaria Council’ to keep the spotlight on the global campaign to eradicate malaria. The announcement was made during the annual World Economic Forum in Davos, Switzerland in January 2017.

An investigation conducted by the international medical organisation Médecins Sans Frontières/Doctors Without Borders (MSF) revealed that over a 1,000 people in a remote area of the Democratic Republic of Congo (DRC) ingested pills of diazepam which actually contained haloperidol.

Congratulations to Prof Sir Nicholas White, former chair of the WWARN Board, who was recently appointed a Knight Commander of the Order of St Michael and St George for services to tropical medicine and global health.

We are pleased to share with you the launch of the first malaria therapeutic area data standard (TAUG-malaria), developed in close partnership with the Clinical Data Interchange Standards Consortium (CDISC). CDISC facilitates the development of standards that support clinical data gathering, exchang...

A new project funded by the French 5% Initiative on AIDS, Tuberculosis and Malaria has launched to provide close to real-time information on the prevalence and distribution of molecular markers of ACT drug resistance across the Mekong Greater Subregion.

Poor women in remote areas are the least likely to receive adequate health care. This is particularly true for regions with insufficient skilled health workers, such as in sub-Saharan Africa and South Asia.

New pharmacokinetic model has enabled revised dose regimen to safely treat all malaria patients with DP, including young children.

Researchers have investigated the efficacy and pharmacology parameters of the commonly used artemisinin combination therapy, artemether-lumefantrine (AL), in children with severe malnutrition and compared it with those who were not malnourished.

Study suggests deployment or rotation of multiple first-line antimalarial medicines will effectively treat malaria and maintain drug efficacy.

Over the past decade, the global health community has made huge gains in the battle against malaria. The World Health Organization’s annual World Malaria Report, out this week, highlights gains in vulnerable populations and challenges in global coverage.

In an article published today in The BMJ’s online Christmas edition, Prof Paul Newton, Head of the Medicine Quality Group at the Infectious Diseases Data Observatory, visits the history of falsified medicines and highlights what needs to be done to avert a problem that threatens us all.